ID

16007

Description

Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00050141

Lien

https://clinicaltrials.gov/show/NCT00050141

Mots-clés

  1. 02/05/2016 02/05/2016 -
  2. 26/06/2016 26/06/2016 -
Téléchargé le

26 juin 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Breast Cancer NCT00050141

Eligibility Breast Cancer NCT00050141

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
locally advanced, inoperable loco-regionally-recurrent, or metastatic breast cancer
Description

breast cancer spreading status

Type de données

boolean

Alias
UMLS CUI [1]
C0278493
UMLS CUI [2,1]
C0027627
UMLS CUI [2,2]
C0205187
estrogen and/or progesterone positive disease
Description

hormone receptor status

Type de données

boolean

Alias
UMLS CUI [1]
C0019929
progression of disease after antiestrogen therapy
Description

progression of disease after antiestrogen therapy

Type de données

boolean

Alias
UMLS CUI [1,1]
C0242656
UMLS CUI [1,2]
C0279025
measurable disease
Description

measurable disease

Type de données

boolean

Alias
UMLS CUI [1]
C1513041
postmenopausal
Description

postmenopausal

Type de données

boolean

Alias
UMLS CUI [1]
C0232970
eastern cooperative oncology group (ecog) performance status 0, 1, or 2.
Description

ECOG performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous endocrine therapy, other than antiestrogen therapy
Description

prior hormone therapy

Type de données

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0279025
more than 1 prior chemotherapy regimen
Description

prior chemotherapy regimen

Type de données

boolean

Alias
UMLS CUI [1]
C1514457
previous therapy with farnesyl transferase inhibitor
Description

previous therapy with farnesyl transferase inhibitor

Type de données

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C1517132
presence of rapidly progressive, life-threatening metastases
Description

mestastases

Type de données

boolean

Alias
UMLS CUI [1,1]
C2826244
UMLS CUI [1,2]
C0027627
concomitant anticancer treatment
Description

concomitant anticancer treatment

Type de données

boolean

Alias
UMLS CUI [1]
C0920425
other malignancy within the past 5 years
Description

former malignancies

Type de données

boolean

Alias
UMLS CUI [1]
C0006826
symptomatic peripheral neuropathy.
Description

symptomatic peripheral neuropathy

Type de données

boolean

Alias
UMLS CUI [1]
C0031117

Similar models

Eligibility Breast Cancer NCT00050141

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
breast cancer spreading status
Item
locally advanced, inoperable loco-regionally-recurrent, or metastatic breast cancer
boolean
C0278493 (UMLS CUI [1])
C0027627 (UMLS CUI [2,1])
C0205187 (UMLS CUI [2,2])
hormone receptor status
Item
estrogen and/or progesterone positive disease
boolean
C0019929 (UMLS CUI [1])
progression of disease after antiestrogen therapy
Item
progression of disease after antiestrogen therapy
boolean
C0242656 (UMLS CUI [1,1])
C0279025 (UMLS CUI [1,2])
measurable disease
Item
measurable disease
boolean
C1513041 (UMLS CUI [1])
postmenopausal
Item
postmenopausal
boolean
C0232970 (UMLS CUI [1])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status 0, 1, or 2.
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
prior hormone therapy
Item
previous endocrine therapy, other than antiestrogen therapy
boolean
C1514463 (UMLS CUI [1,1])
C0279025 (UMLS CUI [1,2])
prior chemotherapy regimen
Item
more than 1 prior chemotherapy regimen
boolean
C1514457 (UMLS CUI [1])
previous therapy with farnesyl transferase inhibitor
Item
previous therapy with farnesyl transferase inhibitor
boolean
C1514463 (UMLS CUI [1,1])
C1517132 (UMLS CUI [1,2])
mestastases
Item
presence of rapidly progressive, life-threatening metastases
boolean
C2826244 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
concomitant anticancer treatment
Item
concomitant anticancer treatment
boolean
C0920425 (UMLS CUI [1])
former malignancies
Item
other malignancy within the past 5 years
boolean
C0006826 (UMLS CUI [1])
symptomatic peripheral neuropathy
Item
symptomatic peripheral neuropathy.
boolean
C0031117 (UMLS CUI [1])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial